Stay updated on RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for the RO6958688 and atezolizumab study is displayed, with its study overview, participant criteria, treatment arms, outcomes, and locations. The record identifies the study as completed and no longer recruiting.
    Difference
    61%
    Check dated 2026-11-09T00:15:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-02T00:06:39.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice was added announcing NIH website transition updates and explaining that NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T23:57:32.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1. The page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T00:21:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T00:14:08.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removal of the 403 Forbidden text and the Home link indicates the error state was cleared. The study details content is now accessible.
    Difference
    0.5%
    Check dated 2026-09-28T00:25:19.000Z thumbnail image

Stay in the know with updates to RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.